SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway

Bin Zeng1, Zhiwei Sun1, Qiting Zhao1

  • 1Institute of Life Sciences, Chongqing Medical University, Chongqing, China.

Insights

Researchers discovered a new mechanism where Platelet Factor 4 (PF4) inhibits melanoma metastasis by blocking the MAPK/ERK pathway. SPARC enhances this effect, suggesting targeting the cancer cell secretome for new therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Mechanisms of Cancer

Background:

  • Melanoma metastasis is a complex, multistep process.
  • The tumor microenvironment (TME) significantly influences metastatic progression.
  • Understanding the intricate relationship between TME and metastasis is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate a novel mechanism regulating melanoma metastasis.
  • To investigate the role of the SEC23A-PF4-MAPK/ERK axis in metastatic colonization.
  • To explore the potential of targeting the cancer cell secretome for therapeutic strategies.

Main Methods:

  • Utilized OL (oligometastatic) and POL (polymetastatic) melanoma cell lines with distinct metastatic capabilities.
  • Investigated the function of Platelet Factor 4 (PF4) in metastasis.
  • Examined the involvement of the MAPK/ERK signaling pathway and the protein SPARC.

Main Results:

  • Identified a new mechanism where PF4, transported by COPII, inhibits melanoma metastasis.
  • PF4 hinders metastasis by suppressing the MAPK/ERK signaling pathway.
  • SPARC cooperates with PF4 to enhance the inhibition of ERK phosphorylation and melanoma cell metastasis.

Conclusions:

  • The SEC23A-PF4-MAPK/ERK axis represents a key regulator of melanoma metastasis.
  • SPARC enhances the anti-metastatic effects of PF4.
  • Targeting the cancer cell secretome, specifically PF4 and SPARC interactions, offers a promising therapeutic avenue for melanoma treatment.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K